These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 26249687)

  • 1. The soluble Y115E-Y117E variant of human glutaminyl cyclase is a valid target for X-ray and NMR screening of inhibitors against Alzheimer disease.
    DiPisa F; Pozzi C; Benvenuti M; Andreini M; Marconi G; Mangani S
    Acta Crystallogr F Struct Biol Commun; 2015 Aug; 71(Pt 8):986-92. PubMed ID: 26249687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The structure of the human glutaminyl cyclase-SEN177 complex indicates routes for developing new potent inhibitors as possible agents for the treatment of neurological disorders.
    Pozzi C; Di Pisa F; Benvenuti M; Mangani S
    J Biol Inorg Chem; 2018 Dec; 23(8):1219-1226. PubMed ID: 30132075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors for human glutaminyl cyclase by structure based design and bioisosteric replacement.
    Buchholz M; Hamann A; Aust S; Brandt W; Böhme L; Hoffmann T; Schilling S; Demuth HU; Heiser U
    J Med Chem; 2009 Nov; 52(22):7069-80. PubMed ID: 19863057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human glutaminyl cyclase: Structure, function, inhibitors and involvement in Alzheimer's disease.
    Vijayan DK; Zhang KYJ
    Pharmacol Res; 2019 Sep; 147():104342. PubMed ID: 31288079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The first potent inhibitors for human glutaminyl cyclase: synthesis and structure-activity relationship.
    Buchholz M; Heiser U; Schilling S; Niestroj AJ; Zunkel K; Demuth HU
    J Med Chem; 2006 Jan; 49(2):664-77. PubMed ID: 16420052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probing secondary glutaminyl cyclase (QC) inhibitor interactions applying an in silico-modeling/site-directed mutagenesis approach: implications for drug development.
    Koch B; Buchholz M; Wermann M; Heiser U; Schilling S; Demuth HU
    Chem Biol Drug Des; 2012 Dec; 80(6):937-46. PubMed ID: 22967026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of flavonoids on human glutaminyl cyclase.
    Li M; Dong Y; Yu X; Zou Y; Zheng Y; Bu X; Quan J; He Z; Wu H
    Bioorg Med Chem; 2016 May; 24(10):2280-6. PubMed ID: 27061673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying hQC Inhibitors of Alzheimer's Disease by Effective Customized Pharmacophore-Based Virtual Screening, Molecular Dynamic Simulation, and Binding Free Energy Analysis.
    Lin W; Zheng X; Fang D; Zhou S; Wu W; Zheng K
    Appl Biochem Biotechnol; 2019 Apr; 187(4):1173-1192. PubMed ID: 30187344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structures of glutaminyl cyclases (QCs) from Drosophila melanogaster reveal active site conservation between insect and mammalian QCs.
    Koch B; Kolenko P; Buchholz M; Carrillo DR; Parthier C; Wermann M; Rahfeld JU; Reuter G; Schilling S; Stubbs MT; Demuth HU
    Biochemistry; 2012 Sep; 51(37):7383-92. PubMed ID: 22897232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structures of human Golgi-resident glutaminyl cyclase and its complexes with inhibitors reveal a large loop movement upon inhibitor binding.
    Huang KF; Liaw SS; Huang WL; Chia CY; Lo YC; Chen YL; Wang AH
    J Biol Chem; 2011 Apr; 286(14):12439-49. PubMed ID: 21288892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrazides Are Potent Transition-State Analogues for Glutaminyl Cyclase Implicated in the Pathogenesis of Alzheimer's Disease.
    Kupski O; Funk LM; Sautner V; Seifert F; Worbs B; Ramsbeck D; Meyer F; Diederichsen U; Buchholz M; Schilling S; Demuth HU; Tittmann K
    Biochemistry; 2020 Jul; 59(28):2585-2591. PubMed ID: 32551535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structures of human glutaminyl cyclase, an enzyme responsible for protein N-terminal pyroglutamate formation.
    Huang KF; Liu YL; Cheng WJ; Ko TP; Wang AH
    Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13117-22. PubMed ID: 16135565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationship of human glutaminyl cyclase inhibitors having an N-(5-methyl-1H-imidazol-1-yl)propyl thiourea template.
    Tran PT; Hoang VH; Thorat SA; Kim SE; Ann J; Chang YJ; Nam DW; Song H; Mook-Jung I; Lee J; Lee J
    Bioorg Med Chem; 2013 Jul; 21(13):3821-30. PubMed ID: 23643900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble variants of human recombinant glutaminyl cyclase.
    Castaldo C; Ciambellotti S; de Pablo-Latorre R; Lalli D; Porcari V; Turano P
    PLoS One; 2013; 8(8):e71657. PubMed ID: 23977104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure analysis of c4763, a uropathogenic Escherichia coli-specific protein.
    Kim H; Choi J; Kim D; Kim KK
    Acta Crystallogr F Struct Biol Commun; 2015 Aug; 71(Pt 8):1042-7. PubMed ID: 26249697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Snake venom glutaminyl cyclases: purification, cloning, kinetic study, recombinant expression, and comparison with the human enzyme.
    Wang YM; Huang KF; Tsai IH
    Toxicon; 2014 Aug; 86():40-50. PubMed ID: 24814012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of the human MLH1 N-terminus: implications for predisposition to Lynch syndrome.
    Wu H; Zeng H; Lam R; Tempel W; Kerr ID; Min J
    Acta Crystallogr F Struct Biol Commun; 2015 Aug; 71(Pt 8):981-5. PubMed ID: 26249686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystallization of interleukin-18 for structure-based inhibitor design.
    Krumm B; Meng X; Xiang Y; Deng J
    Acta Crystallogr F Struct Biol Commun; 2015 Jun; 71(Pt 6):710-7. PubMed ID: 26057800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structures of glycosylated mammalian glutaminyl cyclases reveal conformational variability near the active center.
    Ruiz-Carrillo D; Koch B; Parthier C; Wermann M; Dambe T; Buchholz M; Ludwig HH; Heiser U; Rahfeld JU; Stubbs MT; Schilling S; Demuth HU
    Biochemistry; 2011 Jul; 50(28):6280-8. PubMed ID: 21671571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermal green protein, an extremely stable, nonaggregating fluorescent protein created by structure-guided surface engineering.
    Close DW; Paul CD; Langan PS; Wilce MC; Traore DA; Halfmann R; Rocha RC; Waldo GS; Payne RJ; Rucker JB; Prescott M; Bradbury AR
    Proteins; 2015 Jul; 83(7):1225-37. PubMed ID: 25287913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.